Patent Diligence Checklist for PE Investment in Indian Product Companies

A private equity investor reviewing an Indian product company is often underwriting more than revenue. The investment thesis may depend on a patented device, manufacturing process, embedded component, technical roadmap or licensing opportunity. Patent diligence should answer a practical question: does the company control the inventions that support value, and can those rights survive growth, financing and an eventual exit?

Why This Matters

Product-company diligence differs from a light startup IP review. The target may already have factories, vendors, overseas customers, group-company arrangements, lenders, exclusive channels or strategic partners. A patent schedule may look strong while the commercial right to use, enforce, transfer or license the invention remains uncertain.

The statutory base is the Patents Act, 1970. Investors should focus on who is entitled to apply, what rights a granted patent confers, how assignments and interests are recorded, when rights expire, and what challenges or revocation exposure may affect value. The Patents Rules, 2003 and current IP India practice materials help translate those points into filing and register checks.

For PE investors, the issue is not academic. Patent gaps can affect valuation, closing conditions, lender comfort, customer warranties, export plans, product exclusivity and buyer interest at exit. Patent findings should therefore flow into the investment committee note and transaction documents, not sit in a separate technical annex.

What Counsel Should Review

Start with a complete patent schedule. Counsel should request Indian and foreign applications, granted patents, inventors, applicants, owners, priority dates, prosecution status, renewal dates, working or commercialization notes, licences and security interests. The schedule should be tested against IP India's public patent search and Patent E-Register, with register extracts preserved in the diligence file.

Then map patents to products. A PE buyer needs to know which claims protect the actual revenue-generating product, which filings support future versions, and which assets are defensive or non-core. A portfolio with many filings may still leave the key product feature uncovered. Conversely, one carefully drafted patent family may matter more than a long list of inactive or irrelevant applications.

Ownership needs separate testing. Review founder invention assignments, employment terms, consultant agreements, university or incubator documents, joint-development agreements, vendor development contracts and group-company transfers. Sections dealing with written assignments and register entries make paper title and recordal evidence central to diligence. If the inventors, applicants and operating company do not line up, the closing plan should identify the corrective documents and Patent Office filings needed.

Counsel should also review prosecution health. Open examination reports, missed response dates, divided applications, amendments, pre-grant or post-grant opposition risk, renewal defaults and foreign-filing decisions can change the investment view. The IP India patent manual resources are useful for current procedural context, but the deal team should still review the target's actual correspondence and deadlines.

Next, test encumbrances. Patents may be licensed exclusively, pledged to lenders, included in customer settlement terms, committed to a standards body, or restricted by a government, university or collaborator arrangement. Any limitation on assignment, sublicensing, enforcement or field of use should be reflected in the deal risk matrix.

Finally, connect diligence to transaction protection. Patent warranties should match the reviewed schedule. Disclosure should identify weak families, unrecorded transfers, licences, disputes, threatened claims and known freedom-to-operate concerns. If patents are central to valuation, the investor may need pre-closing assignments, recordal covenants, consent conditions, escrowed deliverables, indemnities or post-closing prosecution obligations.

Typical Timeline and Cost Range

A focused red-flag patent diligence review for a small Indian product company can often be scoped within 2-3 weeks once patent schedules, register extracts, assignments, prosecution correspondence and commercial documents are available. A larger portfolio, foreign filings, technical claim mapping, opposition history or freedom-to-operate questions may require 4-6 weeks and coordination with patent agents or technical reviewers.

The work should be staged. First confirm owner, status and deadlines. Then map claims to products and revenue. Finally, negotiate remediation, warranties, disclosure and closing conditions before signing or funding.

Common Mistakes

1. Treating the patent list as proof of defensibility. Investors need claim relevance, status, term, ownership and product mapping, not only application numbers.
2. Leaving inventor and contractor title unresolved. A missing assignment can become a closing blocker when the patent supports valuation or lender security.
3. Ignoring licences, pledges and field restrictions. A patent may exist, but the company may not be free to transfer, enforce or commercialize it as the deal assumes.

How KAS & Co. Can Help

KAS & Co. helps PE firms, acquirers and Indian product companies review patent ownership, register evidence, licensing constraints, prosecution status and transaction risk allocation. For a focused diligence scope before signing or funding, contact KAS & Co..

FAQs

1. What patent documents should a PE investor request first?

Ask for a patent schedule, application and grant numbers, prosecution correspondence, renewal records, assignments, employment and consultant invention agreements, licences, security documents and dispute notices.

2. Is register evidence enough to prove patent ownership?

Register evidence is important, but counsel should also review the underlying assignment, inventor documents, board approvals, employment records and any licence or security arrangement affecting control.

3. Should patent diligence include freedom-to-operate work?

Yes, if the investment thesis depends on product launch, manufacturing scale-up, export markets or a technology claim that may face competitor patents. A red-flag review can be staged before deeper clearance.

4. How should patent findings affect the investment documents?

Material gaps should become specific disclosures, warranties, closing conditions, covenants, indemnities or post-closing action items, rather than informal diligence notes.

Sources

• The Patents Act, 1970 - IP India e-version
• The Patents Rules, 2003 - IP India
• IP India - Patent manuals and resources
• IP India - Forms and Official Fees
• IP India - Public Patent Search
• IP India - Patent E-Register